Phase II Randomized Study Evaluating the Efficacy of Panitumumab (VEctibix ) and Trifluridine-Tipiracil (LOnsurf) in Pretreated RAS Wild Type Metastatic Colorectal Cancer Patients: the VELO Trial (VELO)
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT05468892 |
Recruitment Status :
Completed
First Posted : July 21, 2022
Last Update Posted : February 1, 2024
|
Sponsor:
University of Campania "Luigi Vanvitelli"
Information provided by (Responsible Party):
Fortunato Ciardiello, University of Campania "Luigi Vanvitelli"
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : | Completed |
---|---|
Actual Primary Completion Date : | May 31, 2022 |
Actual Study Completion Date : | June 30, 2022 |